Medicare Enrolled
Dr. Michael Rotman, MD
Urology Physician · Lawrence, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rotman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rotman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rotman
Dr. Michael Rotman is an urology physician in Lawrence, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rotman performed 2,225 Medicare services across 1,338 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rotman received a total of $17,309 from 46 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rotman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in NY
$17,309 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,225
Medicare services
Top 32% in NY for urology physician
1,338
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
551 | $76 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
273 | $8 | $20 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
273 | $54 | $150 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
144 | $3 | $50 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
138 | $90 | $408 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
124 | $9 | $100 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
89 | $44 | $400 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
88 | $134 | $900 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
85 | $90 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $144 | $595 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
60 | $6 | $800 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
59 | $26 | $600 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
54 | $354 | $1,200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
42 | $13 | $190 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
31 | $89 | $280 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $112 | $444 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
26 | $214 | $1,500 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $117 | $800 |
| Injection, garamycin, gentamicin, up to 80 mg | 20 | $2 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $161 | $410 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $73 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,309
Total received (2018-2024)
Avg $2,473/year across 7 years
Top 12% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,010 (52.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,413 (42.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$886 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,381
2023
$1,313
2022
$7,304
2021
$1,704
2020
$994
2019
$3,961
2018
$652
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$299
Janssen Biotech, Inc.
$221
Astellas Pharma US Inc
$184
PFIZER INC.
$158
Tolmar, Inc.
$83
Antares Pharma, Inc.
$80
Ferring Pharmaceuticals Inc.
$68
ABBVIE INC.
$64
Teleflex LLC
$61
DENTSPLY IH AB
$43
Bayer Healthcare Pharmaceuticals Inc.
$37
PROGENICS PHARMACEUTICALS, INC.
$23
Endo USA, Inc.
$18
Verity Pharmaceuticals Inc.
$15
Hollister Incorporated
$14
ABC Home Medical Supply, Inc.
$14
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
Acerus Pharmaceuticals Corporation
$5,972
Aytu BioScience, Inc
$3,185
Astellas Pharma US Inc
$1,388
Teleflex LLC
$1,228
Janssen Biotech, Inc.
$1,102
NeoTract Inc.
$621
Antares Pharma, Inc.
$444
Axonics, Inc.
$437
Myriad Genetic Laboratories, Inc.
$324
PFIZER INC.
$264
Tolmar, Inc.
$169
Ferring Pharmaceuticals Inc.
$164
DENTSPLY IH Inc.
$144
Avadel Specialty Pharmaceuticals, LLC
$141
Coloplast Corp
$139
DENTSPLY IH AB
$128
Endo Pharmaceuticals Inc.
$126
Myovant Sciences Inc.
$117
Progenics Pharmaceuticals, Inc.
$113
ABBVIE INC.
$103
UROVANT SCIENCES INC
$90
MEDIVATION FIELD SOLUTIONS LLC
$85
Supernus Pharmaceuticals, Inc.
$66
Blue Earth Diagnostics Limited
$58
Laborie Medical Technologies Corp.
$58
Bayer HealthCare Pharmaceuticals Inc.
$56
Aytu Bioscience, Inc
$54
Merck Sharp & Dohme LLC
$53
Lupin Inc.
$48
TOLMAR Pharmaceuticals, Inc.
$47
Clarus Therapeutics Inc.
$43
Accord Healthcare, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$37
180 Medical, Inc.
$36
Mission Pharmacal Company
$35
Cook Medical LLC
$27
PROGENICS PHARMACEUTICALS, INC.
$23
AbbVie, Inc.
$21
UroGen Pharma, Inc.
$19
Endo USA, Inc.
$18
Janssen Pharmaceuticals, Inc
$16
Verity Pharmaceuticals Inc.
$15
Hollister Incorporated
$14
ABC Home Medical Supply, Inc.
$14
Foundation Medicine, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 60.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · Androgel · Axonics · Axumin · BOTOX · BRACANALYSIS CDX · BRACAnalysis · BRACAnalysis CDx · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · JATENZO · JELMYTO · KEYTRUDA · LOFRIC · LUPRON DEPOT · LoFric · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PROLARIS · PYLARIFY · Prolaris · SPEEDICATH · SUPRAX · SpeediCath · TLANDO · TOVIAZ · Trelstar · UROLIFT · Uribel · UroLift · UroLift ATC System · UroLift System · VaPro · XIAFLEX · XTANDI · XYOSTED · Xtandi · Zilver 635
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Urology physicians within 10 mi
594
Per 100K population
42.8
County median income
$143,408
Nearest hospital
ST JOHN'S EPISCOPAL HOSPITAL AT SOUTH SHORE
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rotman is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 12% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rotman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rotman performed 551 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rotman receive payments from pharmaceutical companies?
Yes. Dr. Rotman received a total of $17,309 from 46 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rotman's costs compare to other urology physicians in Lawrence?
Dr. Rotman's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rotman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lawrence
Browse urology physicians in Lawrence ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Acerus Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Acerus Pharmaceuticals Corporation.
By company
Aytu BioScience, Inc Payments to Doctors
See all physicians who received payments from Aytu BioScience, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology